The coronavirus (COVID-19) pandemic has had an unprecedented impact on people, companies, and markets around the world. Glass Lewis has compiled resources to help you maintain your governance program and navigate proxy season during these challenging times. As the crisis continues, we will continue updating these resources and adding content to address new developments.
Glass Lewis Policy Updates & Thought Leadership
Our contextual approach ensures that we can apply discretion and pragmatism to voting matters as appropriate. Given the dynamic nature of the ongoing crisis, we intend to rely on this feature of our guidelines as opposed to continuously updating them as circumstances develop. However, to promote certainty we have issued specific updates to the following policies:
- Policy Updates
- U.S. Approach to Executive Compensation in the Context of the COVID-19 Pandemic
- EMEA Approach to Executive Compensation in the Context of the COVID-19 Pandemic
- Virtual-Only Meetings (Global, updated for 2021)
- Poison Pills
- U.S. Executive Compensation — webinar in partnership with CGLytics
- Comprehensive Approach, covering:
-
- Compensation / remuneration
- Balance sheets and capital allocation
- Board composition and effectiveness
- Activism and M&A
- Oil and gas
- Shareholder proposals and ESG
- Use of context, discretion and pragmatism in recommendations
-
2020 Proxy Season Resources
- Regulatory Impact — market-by-market summary of changes
- AGM Tracker — global list of shareholder meeting delays
2021 Proxy Season Resources
- Coming soon
Questions?
We hope you find these resources helpful. Please don’t hesitate to contact us if you have additional questions.
Customers: clientservices@glasslewis.com
Public Companies: engage@glasslewis.com
Institutional Investors: grow@glasslewis.com